Collectively, these findings lead us to posit that promoting the non-classical functions of ERβ may be a therapeutic strategy to increase mitochondrial metabolism in adipocytes and, in so doing, improve systemic metabolic health in the setting of obesity. This evidence concerns the gene ESR2 and obesity disorder.